Kirby Suzanne, Rahimi Kiana, Song William, Weiss Elisabeth
Department of Radiation Oncology, Virginia Commonwealth University Health System, Richmond, Virginia.
Adv Radiat Oncol. 2025 Mar 17;10(5):101765. doi: 10.1016/j.adro.2025.101765. eCollection 2025 May.
Adaptive magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) requires expeditious recontouring of target volumes based on daily anatomy. Contouring of the gross tumor volume (GTV) is frequently performed by covering radiation oncologists who may be less familiar with the case than the primary physician (PP). The objective of this study is to determine consistency in GTV contouring between PP and covering physician (CP) and to analyze the effect of resources to support accurate GTV delineation.
Between 2021 and 2023, 59 patients underwent 302 fractions of MRgSBRT at our institution. GTVs were analyzed for the effect of 3 different types of contouring support resources: (a) number of slices of the original GTV, (b) external software displaying original GTV contours, and (c) alerting if GTVs differed > 10% from the original. Differences between physicians and contouring support resources were analyzed for different tumor sites and fractions using 2-tailed test and analysis of variance.
One hundred nineteen out of 302 (39.4%) MRgSBRT treatments were supervised by a CP. The difference in the mean absolute percent volume change of GTV compared with original GTV for PPs (11.1%) versus CPs (4.6%) across all treatment fractions was statistically significant ( = .00006). Significant differences were observed for pancreas (12.8% vs 5.0%, = .03), liver (13.0% vs 4.0%, = .007), and lymph nodes (12.4% vs 2.1%, = .004) with larger volume differences for PPs. No significant differences were observed for tumors of the prostate (3.7% vs 3.6%) and adrenal glands (9.7% vs 12.2%). No significant GTV differences between the 3 contouring support techniques were observed.
Our results show larger GTV changes by PPs for most tumor sites with little impact from contouring support resources. Observed differences might be related to higher contouring confidence of PPs who are more familiar with the case. Further investigation into enhancing contouring support methods is warranted.
自适应磁共振引导立体定向体部放射治疗(MRgSBRT)需要根据每日解剖结构快速重新勾勒靶区体积。大体肿瘤体积(GTV)的勾勒通常由参与放疗的肿瘤医生完成,他们可能不如首诊医生(PP)熟悉病例。本研究的目的是确定PP和参与放疗的医生(CP)之间GTV勾勒的一致性,并分析支持准确GTV勾画的资源的作用。
2021年至2023年期间,我们机构有59例患者接受了302次MRgSBRT治疗。分析了GTV受3种不同类型的轮廓支持资源的影响:(a)原始GTV的层数,(b)显示原始GTV轮廓的外部软件,以及(c)当GTV与原始GTV相差>10%时发出警报。使用双尾检验和方差分析,分析了不同肿瘤部位和分次治疗中医生和轮廓支持资源之间的差异。
302次MRgSBRT治疗中有119次(39.4%)由CP监督。在所有治疗分次中,PP(11.1%)与CP(4.6%)相比,GTV的平均绝对体积变化百分比差异具有统计学意义(=0.00006)。在胰腺(12.8%对5.0%,=0.03)、肝脏(13.0%对4.0%,=0.007)和淋巴结(12.4%对2.1%,=0.004)方面观察到显著差异,PP的体积差异更大。在前列腺(3.7%对3.6%)和肾上腺(9.7%对12.2%)肿瘤方面未观察到显著差异。在3种轮廓支持技术之间未观察到显著的GTV差异。
我们的结果显示,对于大多数肿瘤部位,PP的GTV变化更大,轮廓支持资源的影响很小。观察到的差异可能与更熟悉病例(PP)的更高轮廓勾画信心有关。有必要进一步研究增强轮廓支持方法。